Alzheimer’s pill could reduce brain decline in some high-risk patients, trial suggests
The experimental pill ALZ-801 slowed memory decline by 50% and reduced brain shrinkage in early Alzheimer's patients with APOE4 gene in phase 3 trial.
The experimental pill ALZ-801 slowed memory decline by 50% and reduced brain shrinkage in early Alzheimer's patients with APOE4 gene in phase 3 trial.
Read the full article at:
Fox News →